Live
- DEO suspends teacher accused of sexual assault
- PM ‘cursing’ Congress out of despair: Maharashtra Cong Chief
- Applications are invited for Junior Colleges Scheme District Scheduled Castes Development Officer Ramlal
- A nomination was filed on the second day for the Nagar Kurnool parliamentary seat
- SP Gaikwad inspected the Telangana Amarnath Saleswaram Jatara yatra arrangements
- Rahul Gandhi's decision to contest from Wayanad shows 'lack of confidence': BJP President Nadda
- IPL 2024: Delhi bowlers will go after all of SRH’s top-order batters, says head coach Ricky Ponting
- At Amroha rally, PM Modi sends out ‘meaningful’ message for Muslims and Hindus
- Tripura records highest 79.83 pc voter turnout in Northeast
- The government has to clear the confusion
Government places order for 11 million doses of Covishield
The Checklist For Covishield
The government on Monday placed a purchase order with Serum Institute of India (SII) for 11 million doses of Oxford Covid-19 vaccine, Covishield, each costing Rs 210, including the GST, official sources said. Dispatch of the vaccine is likely to start by late Monday evening, they said.
New Delhi: The government on Monday placed a purchase order with Serum Institute of India (SII) for 11 million doses of Oxford Covid-19 vaccine, Covishield, each costing Rs 210, including the GST, official sources said. Dispatch of the vaccine is likely to start by late Monday evening, they said.
According to the order, each dose of the vaccine has been priced at Rs 200 and with GST of Rs 10 it would cost Rs 210. The HLL Lifecare Limited, a public sector undertaking, issued the supply order on behalf of the Union Health Ministry in the name of Prakash Kumar Singh, Additional Director, Government and Regulatory Affairs at Serum Institute of India (SII).
The Covishield vaccine doses would be initially shipped to 60 consignment points from where those would be distributed further, the sources said. The health ministry is also likely to soon sign a purchase order for another anti-coronavirus vaccine, Covaxin, which has been indigenously developed by Bharat Biotech. Meetings for this was underway, a source said.
